|
|
|
Volumn 32, Issue 25, 2007, Pages
|
|
Re: Zigler J, Delamarter R, Spivak J, et al. Results of the prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of the ProDisc-L total disc replacement versus circumferential fusion for the treatment of 1-level degenerative disc disease. Spine 2007;32:1155-62.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ARTHROPLASTY;
DISABILITY;
HUMAN;
INSTRUMENTATION;
INTERVERTEBRAL DISK;
MULTICENTER STUDY;
NOMENCLATURE;
NOTE;
PROSTHESIS;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
REPRODUCIBILITY;
SAFETY;
SPINE DISEASE;
SPINE FUSION;
TREATMENT OUTCOME;
UNITED STATES;
ARTHROPLASTY, REPLACEMENT;
DEVICE APPROVAL;
DISABILITY EVALUATION;
HUMANS;
INTERVERTEBRAL DISK;
MULTICENTER STUDIES AS TOPIC;
PROSTHESIS DESIGN;
QUESTIONNAIRES;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
REPRODUCIBILITY OF RESULTS;
SPINAL DISEASES;
SPINAL FUSION;
TERMINOLOGY AS TOPIC;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 39049151719
PISSN: None
EISSN: 15281159
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|
